**Abstract**

**Background and purpose:** Although previous studies have suggested that nNOS-derived NO has neuroprotective effects on the development of AD, the underlying molecular mechanisms are not fully elucidated. Here, we investigated whether and how disruption of nNOS dimerization contributes to the development of AD.

**Methods:** Two-month-old hemizygous 5xFAD mice and non-transgenic control, and 6-month-old hemizygous 5XFAD mice and non-transgenic control mice were used in the experiments. A histological investigation for neuronal cell death and CDK5/p35 localization, DHE injection for measurement of ROS increase, LT-PAGE for nNOS dimerization/monomerization, and Western blot for CDK5/p35 expression were performed.

**Results:** No differences in synaptic number or expression of synaptic markers were found in the cortex of 5XFAD mice at 6 months of age compared with control littermates. nNOS dimerization was disrupted in the 5XFAD cortex, accompanied by an increase in ROS production. Furthermore, the levels of p25, a CDK5 activator, increased significantly and it colocalized with nNOS in the 5XFAD cortex.

**Conclusion:** Taken together, our results demonstrate that nNOS dimers are disrupted in the 5xFAD cortex with CDK5 activation, may be involved in the disruption of nNOS dimerization and the development of AD.
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